International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Pharmaceuticals and Personal Care Products (PPSPS) in the Aquatic Environment: Status and Issues in the Republic of Benin

    , , , , , ,

Author Affiliations

  • 1Laboratory of Applied Hydrology, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 2Laboratory of Applied Hydrology, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 3Laboratory of Applied Hydrology, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 4Laboratory of Applied Hydrology, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 5University Laboratory of Occupational Health and Environment, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 6Regional Institute of Public Health, University of Abomey-Calavi, Abomey-Calavi, Benin
  • 7Laboratory of Applied Hydrology, University of Abomey-Calavi, Abomey-Calavi, Benin

Res. J. of Pharmaceutical Sci., Volume 5, Issue (3), Pages 1-15, August,30 (2016)

Abstract

In Benin, next to the formal sales channel of pharmaceutical products there are informal channels that commercialize adulterated products. Pharmaceuticals and personal care products (PPSPS) containing various organic groups, such as antibiotics, hormones, antimicrobial agents, synthetic musks, etc., continue to raise concerns with their persistent and potential threat to the ecological environment and to human health. Although wastewater treatment systems are often faulty or non-existent in Africa and particularly in Benin, no study on the state of contamination in PPSPs is achieved in this continent.

References

  1. Zuccato E., Calamari D., Natangelo M. and Fanelli R. (2000)., Presence of therapeutic drugs in the environment., The lancet, 355(9217), 1789-1790.
  2. Calisto V. and Esteves V. I. (2009)., Psychiatric pharmaceuticals in the environment., Chemosphere, (77), 1257-1274.
  3. Baran W., Adamek E., Ziemiańska J. and Sobczak A. (2011)., Effects of the presence of sulfonamides in the environment and their influence on human health., Journal of Hazardous Materials, 196, 1-15
  4. Carballa M., Omil F., Lema J.M., Lompart M., Garcı́a-Jares C. and Rodrı́guez I. (2004)., Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant., Water Res, (38), 2918-2926.
  5. Nakada N., Tanishima T., Shinohara H., Kiri K. and Takada H. (2006)., Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment., Water Res, (40), 3297-3303.
  6. Kasprzyk-Hordern, Dinsdale R. M. and Guwy A. J. (2009)., The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters., Water Res., 43, 363-380.
  7. Vieno N. M., Härkki H., Tuhkanen T. and Kronberg L. (2007)., Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant., Environ Sci Technol, (41), 5077-5084.
  8. Radjenovic J., Petrovic M., Ventura F. and Barcelo D. (2008)., Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment., Water Res, (42), 3601-3610.
  9. Sridevi P., Chaitanya R. K., Prathibha Y., Balakrishna S. L., Dutta-Gupta A. and Senthilkumaran B. (2015)., Early exposure of 17α-ethynylestradiol and diethylstilbestrol induces morphological changes and alters ovarian steroidogenic pathway enzyme gene expression in catfish, Clarias gariepinus., Environmental Toxicology., 30(4), 439-451.
  10. Alighardashi A., Marie-Noëlle P. and Olivier P. (2008)., Occurrence and fate of pharmaceutical substances in urban wastewater, a literature mini-review., Journal of Water Sciences, 21(4), 413-426.
  11. Assanh J. M. C. (2013)., The fight against counterfeit drugs: drug quality control from the markets of Parakou, Cotonou and Porto Novo., Pharmacy PhD thesis at the University of Abomey Calavi.
  12. Directorate of Pharmacies and Medicines (DPM) (2012)., National List of Essential Drugs for Human Medicine in the Republic of Benin., Directorate of Pharmacies and Medicines Nigeria.
  13. Lergis C. (2005)., The detection of counterfeit drugs by investigation of their authenticity. Pilot study on the illicit drug market in Côte d, Pharmacy doctoral thesis, Nancy I, 99-100.
  14. Fayomi E., Bissagnéne E. and Zohoun T. (1996)., Illegal sale of antibiotics to the international market “Dantokpa“ Cotonou : a serious public health problem (Vente illicite d’antibiotiques au marché international « Dantokpa » de Cotonou : un grave problème de santé publique.)., Med Mal Infect, (11), 77-81.
  15. Martioux J. (1999)., Pharmaceutical market parallel, illegal sales and public health., Journal of Re Me D, 8-22.
  16. Hernando M.D., Mezcua M., Fernández-Albaand A.R. and Barceló D. (2006)., Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments., Talanta, 69(2), 334-342.
  17. Sim W.J., Lee J.W., Lee E.S., Shin S.K., Hwang S.R. and Oh J.E. (2011)., Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures., Chemosphere, (82), 179-186.
  18. Chang X., Meyer MT, Liu X., Zhao Q., Chen H., Chen J., Qiu Z., Yang L., Cao J. and Shu W. (2010)., Determination of antibiotics in sewage from hospitals, nursery and slaughter house, wastewater treatment plant and source water in Chongqing region of Three Gorge Reservoir in China., Environ. Pollut., (158), 1444-1450.
  19. Kolpin D. W., Furlong E. T., Meyer M. T., Thurman E. M., Zaugg S. D., and Barber L. B. (2002)., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance., Environ Sci Technol, (36), 1202-1211.
  20. Linert J., Burki T. and Escher B. L. (2007)., Reducing micro pollutants with source control: substance flow annalysis of 212 pharmaceuticals in faeces and urine., Water Sciences and Technology., (56), 87-96.
  21. Soclo H. H., Garrigues P.H. and Ewald M. (2000)., Origin of polycyclic aromatic hydrocarbons (PAHs) in coastal marine sediments: case studies in Cotonou (Bénin) and Aquitaine (France) areas., Marine Pollution Bulletin, 40(5), 387-396.
  22. Youssao A., Soclo H.H., Bonou C. and Fayomi B. (2011)., Assessment of bioaccumulation of lead in marine animal species and identification of sources of metal contamination by a multi-element analysis of metals (Al, Cd, Cr, Cu, Pb) in the coastal waters of Benin., Int. J. Biol. Chem. Sci., 5(1),188-195.
  23. Heberer T. (2002)., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data., Toxicology Letters, 131(1-2), 5-17.
  24. Alder A. C., McArdell C. S., Golet E. M., Ibric S., Molnar E., Nipales N. S. and Giger W. (2001)., Pharmaceuticals and Care Products in the Environment., ACS Symposium Series, American Chemical Society, 791, 56.
  25. Arikan O. A., Rice C. and Codling E. (2008)., Occurrence of antibiotics and hormones in a major agricultural watershed., Desalination, 226, 121-133.
  26. Moeder M., Schrader S., Winkler M. and Popp P. (2000)., Solid-phase micro extraction–gas chromatography–mass spectrometry of biologically active substances in water samples., J. Chromatogr. A, 873, 95.
  27. Pedersen-Bjergaard S. and Grounhaug Halvorsen T. (2000)., Analysis of pharmaceuticals by micro emulsion electro kinetic chromatography in a suppressed electro osmotic flow environment Chromatographia., Chromatographia, 52, 593.
  28. Houeto P., Carton A., Guerbet M., Auclair AC, Gatignol C. and Lechat P. (2012)., Assessment of the health risks related to the presence of drug residues in water for human consumption: Application to carbamazepine., Regulatory Toxicology and Pharmacology, 62(1), 41-48.
  29. Gracia-Lor E., Sancho J. V. and Hernández F. (2011)., Multi-class determination of around 50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography – tandem mass spectrometry., Journal of Chromatography A, 1218, 2264-2275.
  30. Gros M., Petrović M. and Barceló D. (2006)., Development of a multi-residue analytical methodology based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters., Talanta, 70, 678-690.
  31. Togola A. and Budzinski H. (2008)., Multi-residue analysis of pharmaceutical compounds in aqueous samples., Journal of Chromatography A, 1177, 150-158.
  32. Yu Y., Wu L. and Chang A. C. (2013)., Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants., Science of the Total Environment, 442, 310-316.
  33. Behera S. K., Kim H. W, Oh J. E. and Park H. S. (2011)., Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea., Sci Total Environ, 409, 4351-4360.
  34. Aukidy M., Verlicchi P., Jelic, A., Petrovic M. and Barcelò D. (2012)., Monitoring release of pharmaceutical compounds: Occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy., Science of the Total Environment, 438, 15-25.
  35. Bendz D., PaxéusN. A., Ginn T. R. and Loge F. J. (2005)., Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden., Journal of Hazardous Materials, 122, 195-204.
  36. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H. and Hühnerfuss H. (2004)., Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites., Chemosphere, (56), 583-592.
  37. Oosterhuis M., Sacher F. and terLaak T. L. (2013)., Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data., Science of the Total Environment, 442, 380-388.
  38. Huerta-Fontela M., Galceran M. T. and Ventura F. (2010)., Fast liquid chromatography–quadrupole-linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources., Journal of Chromatography A, 1217, 4212-4222.
  39. Zhou Y.Q., Zha J.M., Xu Y.P., Lei B.L. and Wang Z. J. (2011)., Occurrences of six steroid estrogens from different effluents in Beijing, China., Environ Monit Assess, 184, 1719-1729.
  40. Gros M., Petrović M., Ginebreda A. and Barceló D. (2010)., Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes., Environment International, 36, 15-26.
  41. Piram A., Salvador A., Gauvrit J. Y., Lanteri P. and Faure R. (2008)., Development and optimisation of a single extraction procedure for theLC/MS/MS analysis of two pharmaceutical classes residues in sewage treatment plant., Talanta, 74, 1463-1475.
  42. Cabeza Y., Candela L., Ronen D. and Teijon G. (2012)., Monitoring the occurrence of emerging contaminants in treated wastewater and groundwater between 2008 and 2010. The Baix Llobregat (Barcelona, Spain)., Journal of Hazardous Materials, 239-240, 32-39.
  43. Van H. B. (2014)., Contribution to the study of the presence and future of drug residues in aquatic compartments., PhD thesis at the University of Bordeaux, 1.
  44. Castiglioni S., Bagnati R., Calamari D., Fanelli R. and Zuccato E. (2005)., A multi residue an analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters., Journal of Chromatography A, 1092, 206-215.
  45. Ben W., Qiang Z., Adam C., Zhang H. and Chen L. (2008)., Simultaneous determination of sulfonamides, tetracyclines and tiamulin in swine wastewater by solid-phase extraction and liquid chromatography–mass spectrometry., J Chromatogr A, 1202, 173-180.
  46. García-Galán M.J., Díaz-Cruz M. S. and Barceló D. (2011)., Occurrence of sulfonamide residues along the Ebro river basin: Removal in wastewater treatment plants and environmental impact assessment., Environment International, 37, 462-473.
  47. Xiao Y., Chang H., Jia A. and Hu J. (2008)., Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography–electro spray tandem mass spectrometry., J Chromatogr A, 1214, 100-108.
  48. Pailler J. Y., Krein A., Pfister L., Hoffmann L. and Guignard C. (2009)., Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg., Science of The Total Environment, 407, 4736-4743.
  49. Brown K. D., Kulis J., Thomson B., Chapman T. H. and Mawhinney D. B. (2006)., Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico., Sci Total Environ, 366, 772-783.
  50. Salgado R., Noronha J. P., Oehmen A., Carvalho G. and Reis M. A. M. (2010)., Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology., Water Sci Technol, (62), 2862-2871.
  51. Servos M. R., Bennie D. T., Burnison B. K., Jurkovic A., McInnis R. and Neheli T. (2005)., Distribution of estrogens, 17beta-estradiol and estrone in Canadian municipal wastewater treatment plants., Sci Total Environ, (336), 155-170.
  52. Nakata H. and Shinohara R. (2010)., Concentration of benzotriazole UV stabilizers and polycyclic musks in wastewater treatment plant samples in Japan., T. Isobe, K. Nomiyama, A. Subramanian, S. Tanabe (Eds.), Interdisciplinary studies on environmental chemistry—environmental specimen bank, 51-59
  53. Reiner J. L., Berset J. D. and Kannan K. (2007)., Mass flow of polycyclic musks in two wastewater treatment plants., Arch Environ Contam Toxicol, (52), 451-457.
  54. Adam L., Ailbhe M. and Kevin V. T. (2015)., Recommendations for the inclusion of targeted testing to improve the regulatory environmental risk assessment of veterinary medicines used in aquaculture., Environnement international, 185, 1-4.
  55. Jin-Lin L. and Ming-Hung W. (2013)., Pharmaceuticals and personal care products (PPCP): A review on environmental contamination in China., Environment International, (59), 208-224.
  56. Managaki S., Murata A., Takada H., Tuyen B. C. and Chiemn H. (2007)., Distribution of macrolides, sulfonamides, and trim ethoprim in tropical waters: ubiquitous occurrence of veterinary antibiotics in the Mekong Delta., Environ Sci Technol, (41), 8004-8010.
  57. Tamtam F., Mercier F., Le Bot B., Eurin J., TucDinh Q. and Clément M. (2008)., Occurrence and fate of antibiotics in the Seine River in various hydrological conditions., Sci Total Environ, (393), 84-95.
  58. Kolpin D. W., Skopec M., Meyer M., Furlong E. and Zaugg S. (2004)., Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions., Sci Total Environ, (328), 119-130.
  59. Kim S. D., Cho J., Kim I. S., Vanderford B. J. and Snyder S. A. (2007)., Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters., Water Res., (41), 1013-1021.
  60. Brix R., Postigo C., González S, Villagrasa M., Navarro A. and Kuster M. et. al. (2009)., Analysis and occurrence of alkylphenolic compounds and estrogens in a European river basin and an evaluation of their importance as priority pollutants., Anal Bioanal Chem, 396, 1301-1309.
  61. Noppe H., Verslycke T., De Wulf E., Verheyden K., Monteyne E. and Van Caeter P. (2007)., Occurrence of estrogens in the Scheldt estuary: a 2-year survey., Ecotoxicol Environ Saf, (66),1-8.
  62. Ferguson E. M., Allinson M., Allinson G., Swearer S. E. and Hassell K. L. (2013)., Fluctuations in natural and synthetic estrogen concentrations in a tidal estuary in south-eastern Australia., Water Res, (47), 1604-1615.
  63. Nakada N., Kiri K., Shinohara H., Harada A., Kuroda K. and Takizawa S. (2008)., Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage., Environ Sci Technol, (42), 6347-6353.
  64. Thomas K.V. and Hilton M.J. (2004)., The occurrence of selected human pharmaceutical compounds in UK estuaries., Mar Pollut Bull, (49), 436-444.
  65. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V. and Baumann W. (1999)., Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil., Sci Total Environ, (225), 135-141.
  66. Ramaswamy B. R., Shanmugam G., Velu G., Rengarajan B. and Larsson D. G. J. (2011)., GC–MS analysis and ecotoxicological risk assessment of triclosan, carbamazepine and parabens in Indian rivers., J Hazard Mater, (186), 1586¬-1593.
  67. Peck A. M. and Hornbuckle K. C. (2004)., Synthetic musk fragrances in Lake Michigan., Environ Sci Technol, (38), 367-372.
  68. Karl Fent, Anna A. Weston and Daniel Caminada (2006)., Ecotoxicology of human pharmaceuticals., Aquatic Toxicology, 78(2), 122-159.
  69. Tabata A., Kashiwada S., Ohnishi Y., Ishikawa H., Miyamoto N. and andtoh M. (2001)., Estrogenic influences of estradiol-17 beta, p-nonylphenol and bis-phenol-A on Japanese medaka (Oryziaslatipes) at detected environmental concentrations., Water Sci Technol, 43, 109-116.
  70. Zha J. M., Sun L. W., Zhou Y. Q., Spear P. A., Ma M. and Wang Z. J. (2008)., Assessment of 17α-ethinylestradiol effects and underlying mechanisms in a continuous, multigeneration exposure of the Chinese rare minnow (Gobiocyprisrarus)., Toxicol Appl Pharmacol, 226, 298-308.
  71. Gomez E., Pillon A., Fenet H., Rosain D., Duchesne M. J. and Nicolas J. C. (2005)., Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens and musks., J Toxicol Env Health, 68, 239-251.
  72. Foran C.M., Bennett E.R. and Benson W.H. (2000)., Developmental evaluation of a potential non-steroidal estrogen: triclosan., Mar Environ Res, 50, 153-156.